What is the treatment for Emphysematous Cystitis (infection of the urinary bladder with gas formation)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The primary treatment for emphysematous cystitis is a combination of broad-spectrum antibiotics and bladder drainage, with a treatment duration of 7 to 14 days, adjusted based on clinical response. This approach is based on the most recent evidence from the JAMA network open study 1, which suggests that early appropriate antibiotics targeting common pathogens like Escherichia coli and Klebsiella species is reasonable, with a general treatment approach mirroring that for nonemphysematous UTIs.

Key Considerations

  • Start with intravenous antibiotics such as a fluoroquinolone (e.g., ciprofloxacin 400 mg every 12 hours) or a third-generation cephalosporin (e.g., ceftriaxone 1-2 g daily) plus an antibiotic effective against anaerobes like metronidazole (500 mg every 8 hours) 1.
  • Insert a urinary catheter to ensure continuous bladder drainage.
  • Adjust antibiotics based on urine culture results.
  • Manage underlying conditions, particularly diabetes, by maintaining tight glucose control.
  • In severe cases or those not responding to conservative treatment, consider surgical intervention such as cystectomy or nephrectomy.

Rationale

The treatment of emphysematous cystitis lacks robust data, with recommendations mostly relying on clinical judgment and case studies 1. However, the JAMA network open study 1 provides the most recent and highest quality evidence, suggesting that a treatment approach similar to that for nonemphysematous UTIs is reasonable. The study also notes that percutaneous catheter drainage, along with antibiotics, shows lower mortality for emphysematous pyelonephritis and is advisable in severe cases 1.

Additional Considerations

  • The duration of treatment may vary widely depending on clinical response and whether percutaneous drainage was performed 1.
  • It may be reasonable to treat emphysematous cystitis and pyelonephritis in a similar fashion to other more clinically severe UTIs, such as febrile UTI, pyelonephritis, and gram-negative bacteremia from a urinary source 1.

From the Research

Treatment Overview

The treatment for Emphysematous Cystitis (EC) typically involves:

  • Broad-spectrum antibiotics to target the underlying infection 2, 3, 4
  • Strict glycemic control, particularly in diabetic patients 2, 4
  • Bladder drainage, often through an indwelling bladder catheter 2, 3, 5

Surgical Intervention

In some cases, surgical treatment may be necessary, such as:

  • Retroperitoneal drainage, which can be effective in severe cases with septic shock 5
  • Cystectomy, although this is rarely required in severe cases 4

Alternative Therapies

Other treatment modalities that have been explored include:

  • Hyperbaric oxygen therapy, which has shown rapid resolution of symptoms in some cases 6

Key Considerations

It is essential to note that:

  • Approximately 90% of EC cases can be treated with medical therapy alone, while around 10% require combined surgical treatment 5
  • Prompt diagnosis and treatment are crucial to prevent fatal complications, particularly in diabetic patients 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Emphysematous Cystitis.

Cureus, 2020

Research

Emphysematous cystitis.

Urology, 2010

Research

[SUCCESSFUL TREATMENT OF SEVERE EMPHYSEMATOUS CYSTITIS USING RETROPENITONEAL DRAINAGE: A CASE REPORT].

Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2019

Research

Emphysematous cystitis: rapid resolution of symptoms with hyperbaric treatment: a case report.

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.